Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma model is a research paper published in Neuro-Oncology Advances (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Health Institutes
Grant: RO1CA190223
NCI NIH HHS
Grant: R01 CA190223
National Institutes of Health
Grant: 5R01CA190223-09
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
B*Cured Brain Cancer Research Investigator Grant
Cinelli Family Foundation
Fields of Study
Keywords